300233 金城医药
已收盘 11-20 15:00:00
资讯
新帖
简况
11月20日金城医药创60日新低,大成景恒混合A基金重仓该股
证券之星 · 11-20 17:31
11月20日金城医药创60日新低,大成景恒混合A基金重仓该股
股市必读:金城医药(300233)11月17日董秘有最新回复
证券之星 · 11-18
股市必读:金城医药(300233)11月17日董秘有最新回复
金城医药:截至2026年11月10日,公司股东总户数为28,317户
证券之星 · 11-17
金城医药:截至2026年11月10日,公司股东总户数为28,317户
股市必读:金城医药(300233)股东户数2.83万户,较上期增加0.76%
证券之星 · 11-17
股市必读:金城医药(300233)股东户数2.83万户,较上期增加0.76%
股市必读:金城医药新发布《关于完成工商变更登记及《公司章程》备案的公告》
证券之星 · 11-16
股市必读:金城医药新发布《关于完成工商变更登记及《公司章程》备案的公告》
金城医药(300233.SZ):富马酸比索洛尔片获得药品注册证书
智通财经 · 11-13
金城医药(300233.SZ):富马酸比索洛尔片获得药品注册证书
金城医药:深耕特色医药化工、合成生物学、女性健康科技、高端抗感染、新型烟草五大领域
证券之星 · 11-10
金城医药:深耕特色医药化工、合成生物学、女性健康科技、高端抗感染、新型烟草五大领域
股市必读:金城医药新发布《关于回购股份注销完成暨股份变动的公告》
证券之星 · 11-06
股市必读:金城医药新发布《关于回购股份注销完成暨股份变动的公告》
金城医药(300233)披露回购股份注销完成暨股份变动的公告,11月04日股价上涨2.11%
证券之星 · 11-04
金城医药(300233)披露回购股份注销完成暨股份变动的公告,11月04日股价上涨2.11%
金城医药(300233)10月30日股东户数2.81万户,较上期减少2.92%
证券之星 · 11-04
金城医药(300233)10月30日股东户数2.81万户,较上期减少2.92%
金城医药:截至2026年10月30日,公司股东总户数为28,103户
证券之星 · 11-04
金城医药:截至2026年10月30日,公司股东总户数为28,103户
金城医药(300233)2026年三季报简析:营收净利润同比双双增长
证券之星 · 10-31
金城医药(300233)2026年三季报简析:营收净利润同比双双增长
10月29日金城医药跌5.54%,大成景恒混合A基金重仓该股
证券之星 · 10-29
10月29日金城医药跌5.54%,大成景恒混合A基金重仓该股
金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%
证券之星 · 10-28
金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%
金城医药(300233.SZ)发布前三季度业绩,归母净利润1.45亿元,同比增长357.73%
智通财经 · 10-28
金城医药(300233.SZ)发布前三季度业绩,归母净利润1.45亿元,同比增长357.73%
金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%
证券之星 · 10-22
金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%
金城医药:截至2026年10月20日,公司股东总户数为28,947户
证券之星 · 10-22
金城医药:截至2026年10月20日,公司股东总户数为28,947户
金城医药:截至2026年10月10日,公司股东总户数为29,124户
证券之星 · 10-14
金城医药:截至2026年10月10日,公司股东总户数为29,124户
金城医药(300233)10月13日主力资金净买入191.73万元
证券之星 · 10-14
金城医药(300233)10月13日主力资金净买入191.73万元
股市必读:金城医药新发布《关于为子公司提供担保的公告》
证券之星 · 10-08
股市必读:金城医药新发布《关于为子公司提供担保的公告》
公司概况
公司名称:
山东金城医药集团股份有限公司
所属行业:
医药制造业
上市日期:
2011-06-22
主营业务:
山东金城医药集团股份有限公司的主营业务是医药化工、合成生物学、女性健康科技及高端抗感染领域,拓展新型烟草领域。公司的主要产品是头孢侧链活性酯系列产品、生物制药及特色原料药、制剂以及其他医药化工产品。
发行价格:
18.60
{"stockData":{"symbol":"300233","market":"SZ","secType":"STK","nameCN":"金城医药","latestPrice":10.1,"timestamp":1795158216000,"preClose":10.67,"halted":0,"volume":7343400,"delay":0,"changeRate":-0.0534,"floatShares":378000000,"shares":379000000,"eps":0.4143,"marketStatus":"已收盘","change":-0.57,"latestTime":"11-20 15:00:00","open":10.55,"high":10.58,"low":10.1,"amount":75358100,"amplitude":0.045,"askPrice":10.1,"askSize":1420,"bidPrice":10.09,"bidSize":127,"shortable":0,"etf":0,"ttmEps":0.4143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.67,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":11.74,"lowLimit":9.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":379331587,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":24.37847,"roe":"3.89%","epsLYR":0.12,"committee":-0.579268,"marketValue":3831000000,"turnoverRate":0.0194,"status":1,"floatMarketCap":3821000000},"requestUrl":"/m/hq/s/300233/wiki","defaultTab":"wiki","newsList":[{"id":"2684513025","title":"11月20日金城医药创60日新低,大成景恒混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684513025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684513025?lang=zh_cn&edition=full","pubTime":"2026-11-20 17:31","pubTimestamp":1795167068,"startTime":"0","endTime":"0","summary":"证券之星消息,11月20日金城医药跌5.34%创60日新低,收盘报10.1元,换手率1.94%,成交量7.34万手,成交额7535.81万元。重仓金城医药的公募基金请见下表:根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为大成基金的大成景恒混合A。大成景恒混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112000030273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684938966","title":"股市必读:金城医药(300233)11月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684938966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684938966?lang=zh_cn&edition=full","pubTime":"2026-11-18 02:25","pubTimestamp":1794939916,"startTime":"0","endTime":"0","summary":"截至2026年11月17日收盘,金城医药报收于11.11元,下跌0.71%,换手率1.14%,成交量4.33万手,成交额4835.13万元。董秘最新回复投资者: 请问公司截止2026年11月10日的股东户数是多少?谢谢董秘: 投资者,您好,截至2026年11月10日,公司股东总户数为28,317户。交易信息汇总资金流向11月17日主力资金净流出528.91万元,占总成交额10.94%;游资资金净流入143.13万元,占总成交额2.96%;散户资金净流入385.78万元,占总成交额7.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800001187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300233","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684084296","title":"金城医药:截至2026年11月10日,公司股东总户数为28,317户","url":"https://stock-news.laohu8.com/highlight/detail?id=2684084296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684084296?lang=zh_cn&edition=full","pubTime":"2026-11-17 16:51","pubTimestamp":1794905475,"startTime":"0","endTime":"0","summary":"证券之星消息,金城医药(300233)11月17日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止2026年11月10日的股东户数是多少?谢谢金城医药回复:投资者,您好,截至2026年11月10日,公司股东总户数为28,317户。感谢您的关注本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700029973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684641605","title":"股市必读:金城医药(300233)股东户数2.83万户,较上期增加0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2684641605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684641605?lang=zh_cn&edition=full","pubTime":"2026-11-17 01:37","pubTimestamp":1794850630,"startTime":"0","endTime":"0","summary":"截至2026年11月16日收盘,金城医药报收于11.19元,下跌1.06%,换手率1.41%,成交量5.35万手,成交额6006.17万元。股本股东变化:截至2026年11月10日,金城医药股东户数为2.83万户,较10月30日增加0.76%。股本股东变化股东户数变动截至2026年11月10日,金城医药股东户数为2.83万户,较10月30日增加214.0户,增幅为0.76%;户均持股数量由1.37万股减少至1.34万股,户均持股市值为15.63万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700001039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683657994","title":"股市必读:金城医药新发布《关于完成工商变更登记及《公司章程》备案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683657994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683657994?lang=zh_cn&edition=full","pubTime":"2026-11-16 02:53","pubTimestamp":1794768790,"startTime":"0","endTime":"0","summary":"公司公告汇总:公司于2026年11月13日完成工商变更登记及《公司章程》备案,注册资本由383,874,587元变更为379,331,587元。股本股东变化业绩披露要点机构调研要点公司公告汇总关于完成工商变更登记及《公司章程》备案的公告山东金城医药集团股份有限公司于2026年11月13日完成工商变更登记和《公司章程》备案手续,注册资本由人民币383,874,587元变更为人民币379,331,587元,其他登记事项不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600000963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683731573","title":"金城医药(300233.SZ):富马酸比索洛尔片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2683731573","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683731573?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:49","pubTimestamp":1794559742,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金城医药(300233.SZ)发布公告,公司之全资子公司上海金城素智药业有限公司(以下简称“金城素智”)于近日收到国家药品监督管理局下发的富马酸比索洛尔片《药品注册证书》。富马酸比索洛尔片是一种高选择性的β1-肾上腺受体阻滞剂(心脏选择性),用于高血压、冠心病(心绞痛)、伴有左心室收缩功能减退(射血分数≤35%)的慢性稳定性心力衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1522875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWW","300233","BK0028","MXPmain","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682352818","title":"金城医药:深耕特色医药化工、合成生物学、女性健康科技、高端抗感染、新型烟草五大领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2682352818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682352818?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:36","pubTimestamp":1794281811,"startTime":"0","endTime":"0","summary":"证券之星消息,金城医药11月09日在投资者关系平台上答复投资者关心的问题。临床研究的伦理审查现由内部、合作医院还是外部机构承担?本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000014949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159938","BK0239","BK1161","09939","BK1515","300233","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681005781","title":"股市必读:金城医药新发布《关于回购股份注销完成暨股份变动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681005781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681005781?lang=zh_cn&edition=full","pubTime":"2026-11-06 02:18","pubTimestamp":1793902695,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,金城医药报收于11.82元,上涨1.55%,换手率2.85%,成交量10.6万手,成交额1.25亿元。公司公告汇总关于回购股份注销完成暨股份变动的公告山东金城医药集团股份有限公司本次注销回购股份4,543,000股,占注销前总股本的1.18%,回购金额55,004,340.17元。注销完成后,公司总股本由383,874,587股减少至379,331,587股。本次股份注销已于2026年11月3日经中国证券登记结算有限责任公司深圳分公司审核确认完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600002309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680553050","title":"金城医药(300233)披露回购股份注销完成暨股份变动的公告,11月04日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680553050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680553050?lang=zh_cn&edition=full","pubTime":"2026-11-04 22:24","pubTimestamp":1793802299,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘,金城医药报收于11.64元,较前一交易日上涨2.11%,最新总市值为44.15亿元。该股当日开盘11.45元,最高11.66元,最低11.34元,成交额达1.29亿元,换手率为2.96%。近日,金城医药发布《关于回购股份注销完成暨股份变动的公告》。公告显示,公司本次注销回购股份4,543,000股,占注销前总股本的1.18%,回购金额55,004,340.17元。注销完成后,公司总股本由383,874,587股减少至379,331,587股。本次股份注销已于2026年11月3日经中国证券登记结算有限责任公司深圳分公司审核确认完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400043843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680058204","title":"金城医药(300233)10月30日股东户数2.81万户,较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680058204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680058204?lang=zh_cn&edition=full","pubTime":"2026-11-04 19:39","pubTimestamp":1793792395,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金城医药披露,截至2026年10月30日公司股东户数为2.81万户,较10月20日减少844.0户,减幅为2.92%。在化学制药行业个股中,金城医药股东户数低于行业平均水平,截至10月30日,化学制药行业平均股东户数为3.97万户。从股价来看,2026年10月20日至2026年10月30日,金城医药区间跌幅为10.51%,在此期间股东户数减少844.0户,减幅为2.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400036376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680908871","title":"金城医药:截至2026年10月30日,公司股东总户数为28,103户","url":"https://stock-news.laohu8.com/highlight/detail?id=2680908871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680908871?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:37","pubTimestamp":1793763427,"startTime":"0","endTime":"0","summary":"证券之星消息,金城医药(300233)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月30日A股股东人数是多少?谢谢金城医药回复:投资者,您好,截至2026年10月30日,公司股东总户数为28,103户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400017076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679885226","title":"金城医药(300233)2026年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2679885226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679885226?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:50","pubTimestamp":1793404235,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期金城医药发布2026年三季报。根据财报显示,金城医药营收净利润同比双双增长。截至本报告期末,公司营业总收入20.29亿元,同比上升5.05%,归母净利润1.45亿元,同比上升357.73%。按单季度数据看,第三季度营业总收入5.82亿元,同比上升1.83%,第三季度归母净利润566.31万元,同比上升147.97%。本文数据来源于金城医药2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679547547","title":"10月29日金城医药跌5.54%,大成景恒混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679547547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679547547?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:59","pubTimestamp":1793264387,"startTime":"0","endTime":"0","summary":"证券之星消息,10月29日金城医药跌5.54%创60日新低,收盘报11.26元,换手率3.78%,成交量14.08万手,成交额1.61亿元。大成景恒混合A目前规模为4.12亿元,最新净值3.4753,较上一交易日上涨1.37%,近一年下跌1.54%。大成景恒混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900041062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678446632","title":"金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678446632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678446632?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:47","pubTimestamp":1793184439,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金城医药披露,截至2026年10月20日公司股东户数为2.89万户,较10月10日减少177.0户,减幅为0.61%。在化学制药行业个股中,金城医药股东户数低于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.9万户。从股价来看,2026年10月10日至2026年10月20日,金城医药区间跌幅为9.58%,在此期间股东户数减少177.0户,减幅为0.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800041054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678454094","title":"金城医药(300233.SZ)发布前三季度业绩,归母净利润1.45亿元,同比增长357.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678454094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678454094?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:10","pubTimestamp":1793178603,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金城医药(300233.SZ)发布2026年三季度报告,前三季度,公司实现营业收入20.29亿元,同比增长5.05%。归属于上市公司股东的净利润1.45亿元,同比增长357.73%。归属于上市公司股东的扣除非经常性损益的净利润6809.79万元,同比增长210.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677643956","title":"金城医药(300233)10月20日股东户数2.89万户,较上期减少0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677643956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677643956?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:52","pubTimestamp":1792662779,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金城医药披露,截至2026年10月20日公司股东户数为2.89万户,较10月10日减少177.0户,减幅为0.61%。在化学制药行业个股中,金城医药股东户数低于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.68万户。从股价来看,2026年10月10日至2026年10月20日,金城医药区间跌幅为9.58%,在此期间股东户数减少177.0户,减幅为0.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200030800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300233","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677930386","title":"金城医药:截至2026年10月20日,公司股东总户数为28,947户","url":"https://stock-news.laohu8.com/highlight/detail?id=2677930386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677930386?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:12","pubTimestamp":1792656730,"startTime":"0","endTime":"0","summary":"证券之星消息,金城医药(300233)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月20日A股股东人数是多少?谢谢金城医药回复:投资者,您好,截至2026年10月20日,公司股东总户数为28,947户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200026487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675131425","title":"金城医药:截至2026年10月10日,公司股东总户数为29,124户","url":"https://stock-news.laohu8.com/highlight/detail?id=2675131425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675131425?lang=zh_cn&edition=full","pubTime":"2026-10-14 16:36","pubTimestamp":1791966973,"startTime":"0","endTime":"0","summary":"证券之星消息,金城医药(300233)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年10月9日A股股东人数是多少?谢谢金城医药回复:投资者,您好,截至2026年10月10日,公司股东总户数为29,124户,感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400027741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399621","title":"金城医药(300233)10月13日主力资金净买入191.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399621?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:15","pubTimestamp":1791940552,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,金城医药报收于13.2元,下跌2.15%,换手率2.76%,成交量10.26万手,成交额1.35亿元。近5日资金流向一览见下表:金城医药融资融券信息显示,融资方面,当日融资买入1276.88万元,融资偿还1685.03万元,融资净偿还408.14万元。金城医药主营业务:涵盖医药中间体、原料药、口服及外用制剂以及注射剂的研发、生产和销售等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300233","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673108440","title":"股市必读:金城医药新发布《关于为子公司提供担保的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673108440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673108440?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:42","pubTimestamp":1791402129,"startTime":"0","endTime":"0","summary":"公司公告汇总:金城医药为全资子公司金城生物新增2000万元连带责任担保,担保余额升至2500万元,公司整体对外担保余额19426.00万元,占归母净资产5.30%。公司公告汇总关于为子公司提供担保的公告山东金城医药集团股份有限公司于2026年9月30日与中国农业银行股份有限公司淄博淄川支行签署《保证合同》,为全资子公司山东金城生物药业有限公司提供连带责任保证担保,担保债权最高本金余额为2,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300233","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795315394095,"stockEarnings":[{"period":"1week","weight":-0.107},{"period":"1month","weight":-0.1848},{"period":"3month","weight":-0.2665},{"period":"6month","weight":-0.2986},{"period":"1year","weight":-0.3945},{"period":"ytd","weight":-0.2711}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东金城医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28317人(较上一季度增加0.76%)","perCapita":"13359股","listingDate":"2011-06-22","address":"山东省淄博市淄川区淄川经济开发区双山路1号","registeredCapital":"37933万元","survey":" 山东金城医药集团股份有限公司的主营业务是医药化工、合成生物学、女性健康科技及高端抗感染领域,拓展新型烟草领域。公司的主要产品是头孢侧链活性酯系列产品、生物制药及特色原料药、制剂以及其他医药化工产品。","listedPrice":18.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金城医药(300233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金城医药(300233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金城医药,300233,金城医药股票,金城医药股票老虎,金城医药股票老虎国际,金城医药行情,金城医药股票行情,金城医药股价,金城医药股市,金城医药股票价格,金城医药股票交易,金城医药股票购买,金城医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金城医药(300233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金城医药(300233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}